Tesamorelin/Ipamorelin Blend 10mg Peptides
Built for precise, disciplined research, this blend delivers reliable peptide integrity in every lot.
The Tesamorelin/Ipamorelin Blend is a laboratory research peptide blend (unflavored, neutral profile) from Peptide Scientific Labs, combining two growth hormone–focused peptide analogs with a total strength of 10mg. Each unit is prepared for controlled workflows, with clear batch identification and consistent composition to support reproducible results across studies.
- Tesamorelin – A synthetic growth hormone–releasing hormone analog studied for its role in modulating pituitary growth hormone secretion and related endocrine signaling pathways.
- Ipamorelin – A selective ghrelin receptor agonist researched for targeted growth hormone release characteristics with minimal activity on other pituitary axes.
As a non-edible research material, this blend is intended for protocol development, assay design, and exploratory investigations where consistency and clarity of composition are paramount. Its neutral sensory profile and careful handling help maintain predictable behavior across replicates, supporting method validation and comparative analyses. The product presentation is streamlined for laboratory settings, enabling straightforward incorporation into standard operating procedures without unnecessary complexity.
Quality and trust are central to Peptide Scientific Labs. Each lot is evaluated for identity and purity using advanced analytical methods, including high-performance liquid chromatography and mass spectrometry, with rigorous review before release. Materials are handled in controlled environments to limit bioburden and cross-contamination, and lot-specific documentation provides traceability from receipt through fulfillment. Prepared and fulfilled in the USA, this blend reflects our commitment to purity, consistency, and transparency—core standards that underpin confident, reliable research.
For laboratory research only. Not for human consumption or therapeutic use. Handle in accordance with institutional protocols and applicable regulations. Certificates of analysis and lot documentation are available for qualified researchers.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is TESA/IPA Blend typically studied for?
Researchers generally study this combination for growth-hormone pulse support, IGF-1-related signaling, and body-composition or recovery-oriented endocrine models. The useful nuance for an FAQ is that blends like this are chosen for pathway complementarity, but study relevance still depends on the exact dose ratio disclosed by the vendor.
What is TESA/IPA Blend?
TESA/IPA Blend combines Tesamorelin, a GHRH analog, with Ipamorelin, a ghrelin-receptor agonist. The purpose of the blend is to bring together two different upstream signals that can influence endogenous growth-hormone release. On a site page, it should be described as a research blend for GH-axis and endocrine studies only.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Peptide Scientific Labs are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.